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ABSTRACT
Aims
This study was designed to select lactic acid bacteria with histamine and cholesterol reducing 
abilities to be use as potential probiotics.
Methods and Results
Thirty strains of lactic acid bacteria isolated from an artisanal raw milk cheese were screened for 
their abilities to degrade histamine, reduce cholesterol and hydrolyze bile salts. Strains were also 
screened for safety and probiotic traits, such as resistance to gastrointestinal conditions, adhesion 
to Caco-2 cells. resistance to antibiotics and presence of virulence genes. Two Lactobacillus 
paracasei strains presented high cholesterol- and histamine-lowering abilities, tested negative for 
the presence of virulence genes and showed susceptibility to most important antibiotics. These 
strains were also shown to possess desirable in vitro probiotic properties, revealed by tolerance to 
gastrointestinal conditions and high adhesion to intestinal cells.
Conclusions
Among the screened strains, Lb. paracasei L3C21M6 revealed the best cholesterol and histamine 
reducing abilities together with desirable probiotic and safety features to be used in food 
applications.
Significance and Impact of the Study
The strain L3C21M6 is a good candidate for use as a probiotic with histamine-degrading activity 
and cholesterol lowering effect. In addition, this strain could be use in dairy foods to prevent 
histamine food poisoning. 
Keywords
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Introduction
The probiotic market is predicted to reach $57.4 billion by 2022 driven largely by consumers’ 
interest in preventative healthcare and the desire for natural products (Allied Market Research, 
2016). Probiotics can be consumed in different forms being encapsulated in pills or incorporated 
into dairy foods including yogurt, cheese and other fermented foods (Granato et al. 2010). Most 
probiotics belong to the lactic acid bacteria (LAB) group, and the most commonly used are 
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According to the FAO/WHO (2002), probiotic food products are generally fermented foods 
containing a sufficient amount of viable and active “living nonpathogenic microorganisms” 
(bacteria or yeasts) that, when ingested, are able to confer numerous health benefits on the host. 
Key health-promoting properties of probiotic bacteria rely on their ability to survive passage 
through the gastrointestinal tract (GIT), which depends on several factors including their capacity 
to tolerate the acidic pH of the stomach, as well as bile and digestive enzymes (Gobbetti et al. 
2010) and to adhere to intestinal epithelial cells and/or mucus (Marco et al. 2006). 
Different studies in humans have provided evidence of the beneficial effects of probiotics. 
Consumption of probiotics has been shown to stimulate the growth of beneficial microorganisms 
and reduce pathogen load, to alleviate certain intolerances (such as lactose intolerance), and to 
prevent or reduce allergies (Isolauri 2001; Tang et al. 2015). Clinical evidence also exists for 
probiotic efficacy in several conditions including irritable bowel syndrome, constipation, diarrhea, 
bacterial vaginosis, hepatic steatosis and treatment of high cholesterol (Plaza-Diaz et al. 2014; 
Puebla-Barragan and Reid, 2019). In addition, certain LAB may improve the health-promoting 
potential of probiotic foods by degrading anti-nutritional compounds such as biogenic amines and 
cholesterol (Chiang and Pan 2012; Trautvetter et al. 2012). 
The consumption of fermented foods, and especially cheese, with high concentrations of 
biogenic amines, can cause food poisoning such as histamine intoxication, mimicking an allergic 
reaction (EFSA 2011). In individuals with histamine intolerance, ingestion of food with normal 
contents of histamine causes histamine-mediated symptoms, and has been associated with a 
number of inflammatory and neoplastic diseases, such as Crohn disease, ulcerative colitis, allergic 
enteropathy, food allergy and colorectal neoplasms (Maintz and Novak 2007; Ladero et al. 2010). 
Therefore, the use of LAB capable of decreasing the concentration of histamine in foods and in the 
GIT should lead to a reduction in incidence of histamine poisoning and the relief of adverse 
reactions in individuals with histamine intolerance.
High blood cholesterol (hypercholesterolemia) is a risk factor for cardiovascular disease, 
which remains one of the largest causes of death worldwide (Ishimwe et al. 2015). Probiotic 
supplements have been shown to significantly reduce serum total cholesterol in humans (Wang et 
al., 2018). The mechanisms proposed for these cholesterol-lowering effects include deconjugation 
of bile salts by bacterial bile salt hydrolase (Yıldız et al. 2011). Therefore, the ability of LAB to 
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In a previous study, LAB strains were isolated from artisanal Pico cheese and evaluated on basis 
of technological, safety and consumer preference (Domingos-Lopes et al. 2017). Thirty strains 
with QPS status (Lactobacillus, Lactococcus and Leuconostoc genus) showed absence of beta-
hemolysis, DNAse, gelatinase and histamine production, in addition to suitable technological 
features. The objective of the present study is to identify potential probiotic strains from this 
group. Therefore, we evaluated the in vitro probiotic potential of these LAB strains concerning 
their safety and ability to degrade histamine, reduce cholesterol and hydrolyze bile salts. In 
addition, 
Materials and methods
Bacteria strains and growth conditions 
A total of 30 LAB strains were previously isolated from Pico cheese (Domingos-Lopes et al. 
2017) and identified as Leuconostoc mesenteroides (4), Leu. citreum (1), Lactococcus lactis (2), 
Lc. garvieae (1), Lactobacillus plantarum (5), Lb. paraplantarum (1), Lb. paracasei subsp. 
paracasei (15) and Lb. otakiensis (1). Stock cultures were kept at -80 °C in 50% (v/v) glycerol and 
propagated twice in MRS broth (Biokar, Beauvais, France) with 1% (v/v) of inoculum, aerobically 
at 30 °C, for 24 h, before use. 
Assessment of the ability of the LAB strains to degrade histamine
The ability of LAB strains to degrade histamine was tested in a model system similar to that 
previously described by Dapkevicius et al. (2000). LAB strains were tested for their ability to 
degrade histamine in diamine oxidase (DO) broth, consisting of 1 g l-1 glucose, 3 g l-1 yeast 
extract, 3 g l-1 tryptone, 5 g l-1 NaCl, 1 g l-1 Tween 80, 0.25 g l-1 MgSO4·7H2O, 0.038 g l-1 
MnSO4·H2O, 0.08 g l-1 FeSO4.7H2O and 0.05 g l-1 histamine dihydrochloride, pH 6.0. The strains 
were previously grown in MRS broth at 30 °C for 24 h, harvested by centrifugation (5,000 × g, 10 
min, 4°C), washed with phosphate buffer saline (PBS, pH 7.2), and incubated in DO broth (1%) at 
37 ºC, for 30 h. 
The histamine concentration was determined by the spectrofluorometric method of Shore 
(1971). Samples of 1 ml of inactivated broth were added to 9 ml of perchloric acid (0.4 mol l-1) 
and centrifuged at 2,000 × g. The supernatant (2 ml) was added to a mix of 1-butanol, 0.25 ml 
NaOH and 0.75g NaCl (5 ml). The whole mixture was shaken for 5 min and centrifuged for 1 min 
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After 15 min shaking, the whole mixture was centrifuged again and 2 ml of the under layer 
(aqueous-acid phase) was taken for the o-phthaldialdehyde (OPT)-reaction. The OPT reaction was 
done with the addition of 0.4 ml of NaOH (1mol l-1) to the aqueous acid phase (2 ml) and 0.1 ml 
of OPT-reagent (1 g OPT in 100 ml methanol). This mixture was mixed and allowed to stand at 
room temperature for 4 min. The reaction was stopped with 0.2 ml HCl (3 mol l-1) and histamine 
content was measured with a fluorescence spectrophotometer (Fluostar Omega, BMG), at a 360 
nm excitation and 450 nm emission wavelengths. All determinations were carried out in triplicate. 
The percentage of histamine degradation was calculated as follows: % Histamine degradation = [1 
- (residual histamine in the DO broth)/(histamine content of the control DO broth)]×100. Results 
are expressed as the average of three independent experiments.
Determination of cholesterol-lowering activity
The LAB strains were assessed for cholesterol-lowering activity in MRS liquid broth 
supplemented with cholesterol, according to Damodharan et al. (2015). MRS-CHO broth was 
prepared with MRS broth, 0.05% cysteine-HCl and 500 µg ml-1 (w/v) of cholesterol (Sigma 
Chemical Co., USA). The MRS-CHO broth was inoculated with bacterial culture (2%) and 
incubated at 37 ºC for 24 h. The cholesterol concentration in spent medium was estimated by 
enzymatic colorimetric method (CHOD-PAP cholesterol kit, NS Biotec, Egypt), following the 
manufacturer’s protocol. Cholesterol content of inoculated MRS-CHO broth was compared to 
uninoculated MRS-CHO broth (control) and the percentage of cholesterol removal was calculated 
as follows: % cholesterol reduction = [1 - (residual cholesterol in the broth)/(initial cholesterol 
content of the medium)]×100. Results are expressed as the average of three independent 
experiments. 
Bile salts deconjugation assay
Bile salts deconjugation was measured based on the procedure of  (Solieri et al. 2014). Cultures 
were screened for bile salt hydrolase (BSH) activity by spotting 10 ml of a culture suspension onto 
BSH screening medium which consisted of MRS agar plates supplemented with 0.5% (w/v) 
sodium salt of taurodeoxycholic acid (TDCA; Sigma Aldrich, Milan Italy) and 0.37 g l-1 of CaCl2. 
Plates were incubated at 37 ºC for 48 h.  A positive result was interpreted as the presence 
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were measured to evaluate BSH activity. Results are expressed as the average of three independent 
experiments. 
Screening for probiotic properties 
Resistance to gastric acidity
The methods used and described below were adapted from Argyri et al. (2013). Bacterial cells 
from overnight cultures were harvested (10 000 × g, 5 min, 4 °C), washed twice with sterile PBS 
(pH 7.3), before being re-suspended in 1 ml of PBS, and diluted (1:100) in PBS solution adjusted 
to pH 2.5 to reflect stomach acidity. Resistance was assessed in terms of viable colony counts and 
enumerated in duplicate on MRS agar (Biokar Diagnostics) after incubation at 37 °C for 0, 0.5, 1, 
2, and 3 h, reflecting the time spent by food in the stomach. Results are expressed as the average 
of four independent experiments.  
Resistance to bile acid and pancreatin 
The effect of bile acid and pancreatin on strains was determined as reported by Silva et al. (2015). 
Bacterial cells from overnight cultures were harvested (10,000 × g, 5 min, 4 °C), washed twice 
with PBS buffer (pH 7.3), before being re-suspended in PBS solution (pH 7.3), containing 0.3% 
(w/v) of bile salts and 0.1% (w/v) of pancreatin.  Resistance was assessed in terms of viable 
colony counts and enumerated in duplicate on MRS agar (Biokar Diagnostics) after incubation at 
37 °C for 0, 0.5, 1, 2, and 3 h, reflecting the time spent by food in the small intestine. Results are 
expressed as the average of four independent experiments. 
Adherence to Caco-2 cell line
The strains were examined for their ability to adhere to human colon carcinoma (Caco-2) cells. 
Bacterial adherence to differentiated Caco-2 cells (15 days) was tested as described by Argyri et 
al. (2013) with minor modifications. Caco-2 cells (European Collection of Cell Cultures, ECACC 
09042001) were grown in culture plates pre-coated with rat-tail collagen (Collagen, Type I 
Solution, C3867 Sigma), in Dulbecco’s Modified Eagle’s Medium (D6429, Sigma) supplemented 
with 10% Fetal Bovine Serum (FBS, F2442 Sigma), 1% nonessential amino acids (M7145, Sigma) 
and 1% gentamicin (G1397, Sigma). The cell-line was incubated at 37 °C in a humid atmosphere 
of 5% CO2 and transferred into 24 well tissue culture plates at a seeding density of 104 cells. The 
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formed. Prior to experiments, all bacterial cultures were grown overnight in MRS at 37 °C, 
washed twice with PBS and added to each well (approximately 106 CFU ml-1). Following co-
incubation for 2 h at 37 °C, cells were washed three times with sterile PBS to remove any non-
adherent bacteria. Then, 0.1 ml of trypsin-EDTA solution was added, and the mixture was 
incubated for 10 min at 37 °C in 5% CO2. Each monolayer was disrupted by repeated pipetting 
with 0.4 ml of 0.25% Triton X-100. The number of associated bacteria was determined by plating 
appropriate dilutions of the lysate onto agar plates and incubating for 48 hours at 37 °C. All the 




Susceptibility to antibiotics was performed by the disc diffusion method, according to CLSI 
(2016). Antibiotic discs (Oxoid, England) were used to determine the susceptibility of the strains 
to 22 antibiotics: β-lactams (combinations) - amoxicillin/clavulanic acid (20/10 g/disc); 
penicillins - carbenicillin (100 g/disc), penicillin (10 IU/disc) and piperacillin (100 g/disc); 
cephalosporins - ceftazidime (30 g/disc), ceftriaxone (30 g/disc), cefotaxime (30 g/disc) and 
cephalotin (30 g/disc); aminoglycosides - gentamicin (10 g/disc), kanamycin (30 g/disc), 
netilmicin (30 g/disc), streptomycin (10 g/disc) and tobramycin (10 g/disc); amphenicols -  
chloramphenicol (30 g/disc), lincosamides - clindamycin (2 g/disc); macrolides - erythromycin 
(15 g/disc), quinolones - nalidixic acid (30 g/disc) and ofloxacin (5 g/disc); rifamycins  - 
rifampicin (5 g/disc), sulfonamides - trimethoprim/sulfamethoxazole (1.25/23.75 g/disc), 
tetracyclines - tetracycline (30 g/disc); and glycopeptides - vancomycin (30 g/disc). Analyses 
were done in duplicate. The discs were placed onto the surface of inoculated Mueller-Hinton 
(AES, France) agar plates seeded with LAB strains that had been previously grown in MRS broth 
for 24 h - 48 h at 30°C. After incubation at 30°C for 24 h, the diameter of inhibition halos around 
the disks was measured with a digital calliper (Absolute Digimatic Caliper, Mitutoyo, USA), to 
assess the susceptibility or resistance of the examined isolates. Each isolate was characterized as 
sensitive (S) or resistant (R) according to the inhibition zone diameters in agreement with the 
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Presence of virulence genes 
The strains were tested for the presence of virulence genes: gelatinase (gelE), hyaluronidase (hyl), 
aggregation substance (asa1), enterococcal surface protein (esp), cytolisin (cylA), endocarditis 
antigen, (efaA), collagen adhesion (ace), antibiotic resistance genes (vanA and vanB, both related 
to vancomycin resistance), and genes for histidine decarboxylase (hd2), as reported previously by 
Ribeiro et al. (2014). E. faecalis (Ribeiro et al. 2014) and E. faecium (Lopez et al. 2009) strains 
were used as positive controls in the corresponding PCR reactions. 
Statistical analysis
Data are expressed as means ± SEM. Principal Component Analysis (PCA) with varimax rotation 
was done to group strains based on functional properties (degradation of histamine, cholesterol 
reduction after 24h and 48h, and bile salts deconjugation). In vitro adhesion to Caco-2 cells by 
different strains were compared and analyzed by One-Way ANOVA. Differences were considered 
statistically significant at P < 0.05. Statistical analyses were performed with SPSS software 
package (IBM SPSS Statistics 20, IBM Corporation, New York, USA). 
Results
Functional properties
Thirty autochthonous strains were previously screened for their ability to produce 
histamine by decarboxylation of histidine, and all tested negative for histamine production 
(Domingos-Lopes et al. 2017). The histamine degrading, cholesterol reducing and bile salts 
deconjugating abilities of these strains are summarized in Table 1. Sixteen strains present high 
histamine reduction potential as they degraded histamine to over 50% of its initial concentration in 
culture medium. Among them, three strains of Lb. paracasei (L2A1K8, L2B1K8 and L3B21R2), 
one Leu. mesenteroides (L3A21M4) and one Lb. plantarum (strain 11, L2C21E8) were most 
active in removing histamine (>58% reduction). 
The ability of the strains to reduce cholesterol in vitro also varied between strains and 
among species (Table 1). Cholesterol removal increased from a range of 15–58% after 24 h, and a 
range of 20–66% after 48 h. The highest percentage of cholesterol reduction was achieved by Lb. 
paracasei strain L3B1M2 (22), lowering cholesterol by 54% and 66%, after 24 h and 48 h, 
respectively. Lb. paracasei L3B21R1 strain (23) also presented a high degree of cholesterol 
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lowering ability (46%). Likewise, Leu. mesenteroides strain L2B21E3 (2) presented a high degree 
of cholesterol removal after 48 h (60%) and moderate histamine degradation capacity (41%). 
Moreover, strains Lb. paracasei L2B1K8 (20), L3B21R2 (24) and L3C21M6 (28) presented high 
capacity to reduce cholesterol (>50%, after 48h) in association to high capacity to degrade 
histamine (>50%).
Deconjugation of bile salts was also observed for all the strains tested. All the 30 LAB 
strains screened showed the precipitation zone ranging from 12 to 15 mm (Table 1). Curiously, the 
species/strains showing high bile salt hydrolase (BSH) activities (14-15 mm) presented lower 
ability for cholesterol removal (strains 3 to 9, 17 and 30).
Principal component analysis was applied to group the strains according to their different 
capacities to degrade cholesterol, histamine and bile salts. The first two axes accounted for 74% of 
the total variation and distributed the strains into five distinct groups (A, B, C, D and E, Figure 
1a). Principal component 1 (PC-1) accounted for 49% of variation (Fig. 1b) and was mainly 
responsible for grouping the strains according to cholesterol reduction after 24 h and 48 h. 
Principal component 2 (PC-2) accounted for 25% of variation and was responsible for grouping 
the strains according to histamine reduction and BSH activity (Fig. 1b). Cluster A is the largest 
group (14 strains) and includes strains with high histamine reduction ability, but reduced capacity 
to degrade cholesterol (Fig. 1a). Strains clustered in group B (strains 20, 24 and 28) presented high 
capacity to reduce both cholesterol and histamine, but smaller BSH activity (Fig. 1a). Strains 
clustered in the group C (strains 22 and 23) showed high capacity for cholesterol reduction but 
lower capacity for histamine reduction and bile salt deconjugation (Fig. 1a). Cluster D contains 
five strains (1, 13, 14, 21 and 26) showing all together low values of histamine degradation, 
cholesterol removal and BSH activity (Fig. 1a). Finally, group E includes the strains with reduced 
capacity to degrade both histamine and cholesterol, but high BSH activity (strains 2, 4, 5, 6, 9 and 
10, Fig. 1a). 
Probiotic properties
The survival of LAB strains under low pH (2.5) is presented in Fig.2a. Generally, all 
strains showed poor resistance to the gastric environment as demonstrated by the rapid loss of 
viability after exposure to pH 2.5 (Fig. 2a). Leu. mesenteroides (L2B21E3), Lb. plantarum 
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highest survival to acidic conditions for 2 h. Only one strain (strain 9, Lb. plantarum LA21R1) 
was detectable (1.6 log CFU ml-1) after 3 h of exposure to the acidic conditions. 
In contrast to poor resistance to acidic conditions, most strains were found to be tolerant to bile 
salts and pancreatin (Fig. 2b). In fact, even after 3 h of exposure, most strains retained their 
viability. In contrast, two strains (Leu. mesenteroides L3A21M4 and Lb. paracasei L2B1K8) 
demonstrated an important loss in viability after 3 h and one Lb. paracasei (L3B21K4) was highly 
sensitive to bile salts and pancreatin (undetectable after two hours of exposition). Other strains, 
including Leu. mesenteroides L2B21E3 (strain 2) and Lb. paracasei L3B1M2 and L3B21R1 (22 
and 23), exhibited survival greater than 80% after 3 h in the presence of bile salts and pancreatin 
(Fig. 2b).
The probiotic potential of strains was also evaluated for their ability to colonize the GIT 
epithelial cells. The efficiency of each strain's capacity to adhere to a Caco-2 cell line is presented 
in Fig. 2c. In general, all strains displayed high adhesion capacity to Caco-2 cells and no 
significant differences (P > 0.05) were found between strains.
Safety
The antibiotic susceptibility of the LAB strains is presented in Fig. 3. All strains were sensitive to 
amoxicillin/clavulanic acid, chloramphenicol, carbenicillin, penicillin, piperacillin and 
tetracycline. Most of the strains were resistant to aminoglycosides (kanamycin, streptomycin and 
tobramycin), with the exception of netilmicin. Few strains were resistant to erythromycin (Lc. 
garvieae L3B1M8), cefalotin (Lb. paraplantarum L2B21R5 and Lb. paracasei L3B21R2), 
ofloxacin (Lb. paracasei L2B21R1a) and rifampicin (Leu. mesenteroides L2B21E3 and Lc. lactis 
L3A21M1). Vancomycin resistance was found in three strains of Leu. mesenteroides (strains 
L2A21E7, L3A21M4 and L3C21R7), two Lb. plantarum (strains L2B21R1b and L3C1E8) and 
four Lb. paracasei (strains L2A1K8, L2B1K8, L3A21R8 and L3B1K1). 
The results of evaluation of the virulence potential of the strains are presented in Table 2. 
None of the strains harbored the gene for the hyaluronidase (hyl). The gene for endocarditis (efaA) 
was more common, detected in the majority of strains, with the exception of one Leu. 
mesenteroides (strain 4, L3C21R7) and seven Lb. paracasei (strains 16, 17, 18, 19, 22, 26 and 28, 
L2A1K8, L2A21K5, L2B21R1a, L2B21R3, L3B1M2, L3B1K1 and L3C21M6, respectively). 
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L3C21R7 and strains 16, 18, 19, 22, 28, Lb. paracasei L2A1K8, L2B21R1a, L2B21R3, L3B1M2, 
L3C21M6, respectively) tested negative for all the virulence genes studied.
Discussion
Large amounts of histamine and other biogenic amines can be found in a variety of foods, 
particularly in fish, cheese and other fermented food products (Doeun et al. 2017; Park et al. 
2019). Several studies have described the use of bacteria for reducing biogenic amine 
concentrations in foods, especially in fermented products (Dapkevicius et al. 2000; Zaman et al. 
2010; Lee et al. 2016). Dietary-derived biogenic amines are mainly metabolized in the digestive 
tract by diamine oxidase (DAO) (Kawashima et al. 2011). Reduced DAO activity in individuals 
can lead to histamine intolerance. Therefore, the presence of probiotic bacteria with biogenic 
amine-degrading activities may be useful to help detoxification, particularly when intestinal DAO 
is reduced. 
Among biogenic amines, histamine is the most likely to cause food poisoning (Izquierdo-
Casas et al. 2019). In this study, high percentages of histamine degradation (over 50%) were 
detected for sixteen strains, making these good candidates for probiotic use (Table 1). 
Remarkably, all strains showed the ability to degrade histamine, with a large variation between the 
strains. Similarly, Zaman et al (2009) found that all the bacteria isolated from fish sauce which did 
not produce biogenic amines, had the ability to degrade histamine, although with different 
efficiencies (in the range from 5% to 60%).  The percentages of histamine degradation were 
slighter higher in the present study (29% to 60%), but these results were comparable to the study 
of Dapkevicius et al. (2000). In their study, lactobacilli isolated from naturally fermented fish 
pastes were found to reduce histamine by 20–56% in culture media enriched with histamine, but 
the percentage of positive strains was very low. However, the different source of LAB may be 
responsible by this result, since scombroid fish is frequently a source of histamine-food poisoning. 
Studies concerning histamine degradation by LAB isolated from cheese are scarce. The few 
studies concerning histamine degradation are related to LAB isolated from fermented fish because 
this food, in particular scombroid fish, is one of the main sources of histamine food-poisoning. 
Although from a different matrix, LAB isolated from cheese share similarities with fish isolates, 
included the ability to degrade histamine. In a different study, Leuschner et al. (1998) found 27 
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source. Herrero-Fresno et al. (2012) also found a reduced number of Lb. casei strains (17 out of 
157) presenting over 25% of histamine degradation rate, but they were isolated from high biogenic 
amine cheeses. 
In the present study, 14 strains were clustered in group A of the PCA plot (Fig. 1a) that 
showed high histamine reduction ability, although reduced capacity to degrade cholesterol. This 
cluster was dominated by Lb. paracasei (9 strains), although other species were also included, 
such as Lb. plantarum, Lc. garvieae, Lc. lactis and Leu. mesenteroides. These strains have the 
potential to be used as probiotics in individuals with reduced DAO activity, but also in food 
fermentations to reduce histamine content. The mechanism involved in histamine reduction by 
these strains is unknown, but other studies described the amino-oxidase activity of food-
fermenting microorganisms as a way to reduce biogenic amines (Leuschner et al. 1998).
Cholesterol-lowering ability is also an important trait for probiotic bacteria. Some studies 
have revealed a relationship between consumption of fermented dairy products and a reduction of 
serum cholesterol levels in humans and animals (Andrade and Borges 2009; Hjerpsted et al. 2011; 
Yadav et al. 2019). The hypocholesterolemic effects of fermented foods were attributed to the 
presence of bacteria able to remove cholesterol in the small intestine (Huang et al. 2014; Michael 
et al. 2017; Zhang et al. 2017). The cholesterol-lowering efficacy of probiotic bacteria was shown 
to be highly strain-specific (Papanikolaou et al. 2012; Zhang et al. 2013; Saravanan et al. 2015; 
Nami et al. 2018). We observed similar results in this study, as LAB strains removed the 
cholesterol in vitro at variable levels (20–66%, after 48 h). However, only two strains of Lb. 
paracasei (L3B1M2 and L3B21R1) were clustered in the group displayed high cholesterol-
lowering efficacy (group C, Fig.1a). These strains showed high levels of cholesterol reduction 
(>50%) after 24 h (Table 1).
Cholesterol removal by bacteria has been shown to improve with the addition of bile salts 
to culture media (Taranto et al. 1997). Previous reports on cholesterol reduction by Lactobacillus 
strains showed high levels (28–86%) of cholesterol reduction in liquid medium supplied with 
0.3% bile oxgall (Yıldız et al. 2011; Papanikolaou et al. 2012). In the present work, some strains 
showed high levels of cholesterol removal (>50%), although no bile salts were used in the culture 
media. 
The mechanisms of cholesterol-lowering activity of LAB include its adsorption to the cell 
wall and assimilation into the cell membrane. The incorporation of cholesterol into the cell 
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tract (Dambekodi and Gilliland 1998; Horáčková et al. 2018). Other mechanisms of cholesterol 
reduction by bacteria involve the conversion of cholesterol to coprostanol and co-precipitation of 
cholesterol with deconjugated bile salts (Yıldız et al. 2011; Gérard 2014). In the present study, 
cholesterol reduction was not observed when cells were not removed by centrifugation (data not 
shown). Therefore, cholesterol adsorption to the cell wall or membrane is likely to be the 
mechanism involved in cholesterol removal from fermentation media by these strains.
Hydrolysis of bile salts by the gut microbiota has been proposed by several authors as an 
additional mechanism for reducing cholesterol (Gérard 2014; Michael et al. 2017). The removal of 
cholesterol by gut bacteria was revealed to be linked to the BSH activity of the cells, releasing 
unconjugated bile acids that induce cholesterol co-precipitation (Taranto et al. 1997; Liong and 
Shah 2005). In this study, all 30 isolates screened showed BSH activity as confirmed by the 
precipitation zone, in agreement with other studies (Saravanan et al. 2015). However, no 
correlation was found between cholesterol reduction and BSH activity by the cells. Similarly, 
Dambekodi and Gilliland (1998) showed no relationship between the ability to deconjugate bile 
salts and cholesterol assimilation by bacteria. Bile salts deconjugation might play a vital role in 
sustaining the stability of the gut microbiota. According to Smet et al. (1995), BSH activity allows 
lactobacilli to persist under harsh intestinal bile stress. In addition, Ma et al. (2019) showed that 
strains exhibiting greater BSH ability in vitro have also higher potential to decrease serum 
cholesterol levels in vivo. However, high BSH deconjugation activity may produce detrimental 
effects for the host. Indeed, if this hydrolysis is more extensive in the gut, it could lead to colon 
cancer, gallstones, and other GIT diseases (McGarr et al. 2005).
PCA plot was effective in showing the differences among strains concerning phenotypic 
features (Fig. 1). Lb. paracasei strains clustered in group B (strains 20, 24 and 28) of the PCA plot 
displayed the highest functional properties, because they showed higher activities for cholesterol 
and histamine removal, while they presented satisfactory BSH activity (12.5-13.5 mm). Among 
the strains clustered in this group, strain 20 (Lb. paracasei L2B1K8) was the least tolerant to acid 
and bile salts and pancreatin. In addition, this strain also presented the lowest adhesion to Caco-2 
cells (<104 UFC cm-2). The remaining two strains (24 and 28) showed similar tolerance to GIT 
conditions and adhesion to Caco-2 cells did not differ significantly (P > 0.05). However, strain 28 
(Lb. paracasei L3C21M6) held the highest probiotic traits, including both cholesterol, histamine 
and BSH activities. Both these strains were considered safe, as they were sensitive to most of the 
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aminoglycoside resistance has been described as an intrinsic feature of Lactobacillus species 
(Campedelli et al. 2019). In addition, Lb. paracasei L3C21M6 tested negative for all virulence 
genes. Although expression of genes was not assessed, the presence of virulence genes is a safety 
issue due to the potential transfer to pathogenic bacteria in the gut. 
In a previous study, strain Lb. paracasei L3C21M6 was showed to hold important 
enzymatic properties for dairy application, including high esterase/lipase activities, extracellular 
proteolytic activity and strong production of diacetyl from citrate (Domingos-Lopes et al. 2017). 
This strain was also displayed the ability to produced a pleasant aroma/flavour in experimental 
fresh cheeses (Domingos-Lopes et al. 2017).
In conclusion, the present study revealed that Lb. paracasei L3B21R2 and L3C21M6 
strains isolated from Pico artisanal cheese possessed good cholesterol and histamine-lowering 
abilities and bile salt hydrolase activities. These strains were not only tolerant to gastrointestinal 
conditions but also presented high adhesion to intestinal cells and were considered safe. The 
probiotic potential of Lb. paracasei L3C21M6 is complemented with a previous report of 
desirable technological and sensory characteristics in experimental cheeses. Therefore, Lb. 
paracasei L3C21M6 could be considered as a potential probiotic LAB strain for food and 
technological applications.
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Table 1. Histamine degradation (%), cholesterol removal (%) after 24 and 48 h, and bile salt hydrolase 
activity (diameters of the precipitation zones) of bacterial strains used in the study. 












24 h 48 h 
1 Leu. mesenteroides L2A21E7 KM079353 29.2 ± 5.8 38 ± 6.5 45 ± 2.9 12.0 
2 Leu. mesenteroides L2B21E3 KM079354 41.0 ± 7.1 32 ± 5.6 60 ± 3.2 13.5 
3 Leu. mesenteroides L3A21M4 KM079355 59.6 ± 8.1 32 ± 6.2 37 ± 4.1 15.0 
4 Leu. mesenteroides L3C21R7 KM079356 43.4 ± 8.9  19 ± 2.6 38 ± 7.1 15.0 
5 Leu. citreum L3C1E7 KM079357 35.5 ± 9.3 46 ± 8.1 47 ± 5.5 14.5 
6 Lc. lactis lactis  L3B1M7 KM079358 44.4 ± 8.3 28 ± 8.5 38 ± 5.9 15.0 
7 Lc. garvieae  L3B1M8 KM079359 55.6 ± 9.1 27 ± 4.9 43 ± 5.0 14.5 
8 Lc. lactis  L3A21M1 KF193424 50.3 ± 3.3 36 ± 6.5 45 ± 4.5 14.5 
9 Lb. plantarum  L2A21R1 KM103931 36.6 ± 5.0 31 ± 8.8 39 ± 5.9 14.5 
10 Lb. plantarum L2B21R1b KM103932 39.0 ± 5.0 27 ± 8.9 39 ± 1.3 13.5 
11 Lb. plantarum L2C21E8 KM103933 59.2 ± 8.5 30 ± 3.2 48 ± 8.9 14.0 
12 Lb. plantarum L3A21R6 KM103934 52.7 ± 9.4 34 ± 9.7 39 ± 8.4 13.5 
13 Lb. plantarum L3C1E8 KM079361 43.8 ± 6.9 37 ± 6.2 42 ± 9.8 13.0 
14 Lb. paraplantarum L2B21R5 KM079360 40.8 ± 8.5 32 ± 5.4 34 ± 9.5 13.0 
15 Lb. paracasei  L2A21R9 KM096813 54.2 ± 4.2 33 ± 5.8 34 ± 6.5 13.5 
16 Lb. paracasei  L2A1K8 KM096814 58.4 ± 9.2 37 ± 2.6 39 ± 1.3 12.0 
17 Lb. paracasei  L2A21K5 KM096815 55.8 ± 4.5 31 ± 2.4 39 ± 8.4 14.5 
18 Lb. paracasei  L2B21R1a KM096816 57.8 ± 2.8 35 ± 3.8 37 ± 0.8 13.0 
19 Lb. paracasei  L2B21R3 KM096817 52.3 ± 8.3 24 ± 6.9 34 ± 5.9 12.5 
20 Lb. paracasei  L2B1K8 KM096818 58.1 ± 6.2 39 ± 8.1 52 ± 5.5 12.5 
21 Lb. paracasei  L3A21R8 KM096819 40.3 ± 6.2 38 ± 5.1 47 ± 2.5 13.0 
22 Lb. paracasei L3B1M2 KM096820 40.8 ± 9.5 54 ± 7.0 66 ± 2.5 13.0 
23 Lb. paracasei  L3B21R1 KM096821 46.0 ± 9.4 58 ± 6.0 60 ± 7.1 12.5 
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25 Lb. paracasei  L3B21R7 KM096823 52.0 ± 9.7 15 ± 8.0 20 ± 9.0 12.5 
26 Lb. paracasei  L3B1K1 KM096824 45.1± 8.0 21 ± 2.1 49 ± 5.5 12.5 
27 Lb. paracasei  L3B21K4 KM096825 50.9 ± 7.7 21 ± 0.8 36 ± 9.7 13.0 
28 Lb. paracasei  L3C21M6 KM096826 55.0 ± 5.8 47 ± 3.8 56 ± 0.4 13.5 
29 Lb. paracasei  L3C1K8 KM096827 46.4 ± 8.2 24 ± 4.7 32 ± 0.8 13.5 
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Table 2.  Incidence of virulence genes in LAB strains. The virulence genes tested were 
gelatinase (gelE), hyaluronidase (hyl), aggregation substance (asa1), enterococcal surface 
protein (esp), cytolisin (cylA), endocarditis antigen (efaA), collagen adhesion (ace), resistance 
















gelE hyl asa1 esp cylA efaA ace  vanA vanB  hdc2 
Leu. mesenteroides             
L2A21E7 - - - - + + -  - -  - 
L2B21E3 - - + - - + +  - -  + 
L3A21M4 - - - - - + +  - -  - 
L3C21R7 - - - - - - -  - -  - 
Leu. citreum             
L3C1E7 - - - - - + -  - -  - 
Lc.lactis             
L3B1M7 - - - - - + -  - -  - 
L3A21M1 - - - - - + -  - -  - 
Lc. garvieae             
L3B1M8 - - - - - + -  - -  - 
Lb. plantarum             
L2A21R1 - - - - - + +  - -  - 
L2B21R1b - - - - - + -  - -  - 
L2C21E8 - - - - - + -  - -  - 
L3A21R6 - - - - - + -  - -  - 
L3C1E8 - - - - - + +  - -  - 
Lb. paraplantarum             
L2B21R5 - - - - - + -  - -  - 
Lb. paracasei             
L2A21R9 + - + + + + +  - -  - 
L2A1K8 - - - - - - -  - -  - 
L2A21K5 - - - - - - -  + -  - 
L2B21R1a - - - - - - -  - -  - 
L2B21R3 - - - - - - -  - -  - 










This article is protected by copyright. All rights reserved 
L3A21R8 - - - - - + -  - +  - 
L3B1M2 - - - - - - -  - -  - 
L3B21R1 - - - - - + -  - -  - 
L3B21R2 - - - - + + -  - -  - 
L3B21R7 - - - - + + +  - -  - 
L3B1K1 - - + - - - -  - -  - 
L3B21K4 - - - - - + -  - -  - 
L3C21M6 - - - - - - -  - -  - 
L3C1K8 + - + + - + +  - +  - 
Lb. otakiensis             
L3C1R1 - - + - - + +  - -  - 
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